Transition Therapeutics Announces Appointment of Vice-President of Clinical Operations

22-Jun-2009 - Canada

Transition Therapeutics Inc. announced that Ms. Laura Agensky has been appointed Vice-President of Clinical Operations. Since joining Transition in 2001, Ms. Agensky has managed the execution of all the Company's clinical trials across a diverse set of disease indications including Alzheimer's disease and diabetes. Prior to Transition, she served in multiple clinical development roles at large pharmaceutical, biotechnology and consulting organizations. As Vice-President, Ms. Agensky will continue to lead Transition's clinical operations group.

Other news from the department people

Most read news

More news from our other portals

So close that even
molecules turn red...